Fritextsökning
Innehållstyper
-
Multiple rotor options in refrigerated microcentrifuge
The new 5430 R from Eppendorf is a refrigerated microcentrifuge with several different rotors.
-
Positiva fas II-resultat för Biovitrum
Preparatet Kiobrina påvisar en förbättring av tillväxthastigheten hos för tidigt födda barn när det ges i modersmjölkersättning, jämfört med placebo.
-
Recipharm launches into biologics manufacturing
Recently a Swedish biomanufacturing facility transfers from Astrazeneca to Recipharm Biologics.
-
View pathology images in your iPhone
The Institute for Medical Informatics in Oslo announces a brand new iPhone application for virtual microscopy.
-
Apoteket gets new vice CEO
The Swedish government company Apoteket has recently appointed a vice CEO.
-
Meda gets access to Asia
The biotech giant Meda has recently acquires world-wide rights to the cancer breakthrough pain drug Onsolis.
-
Ten recieve the Venture Cup West Prize
At this year´s Venture Cup West awards the 10 best business ideas in Venture Cup West 08/09 were chosen, receiving SEK 10 000 each.
-
Engelsk biobank öppnas för forskning
Inriktas speciellt på hjärt-kärlsjukdomar, cancer och diabetes.
-
Medtech companies find new beam technique
The medtech companies Raysearch and Nucletron expand collaboration with two new solutions for radiation treatment planning.
-
Swiss allergy therapy convinces
Cytos Biotechnology presents promising results in a study of a new therapy against allergy and asthma.
-
Nya fynd kring diabetes
Genom att använda experimentella tekniker har forskare vid Karolinska Institutet kunnat visa hur de så kallade deltacellerna i en del av bukspottkörteln – de La...
-
New faces in Pronova Biopharma team
The Norwegian company Pronova Biopharma has recently changed the management team structure.
-
Oasmia gets a confirmation
FDA has granted Oasmia an expedited review status for Paclical Vet.
-
Positive combined cancer therapy
Topotarget announces positive data with new treatment against colorectal cancer.
-
Iddo Leshem tar sig an Norden
Iddo Leshem har börjat sin nya roll som general manager för Bristol-Myers Squibb Norden.
-
Vattenfall is firing with biomass
Vattenfall will provide Denmark with electricity by means of biomass.
-
Teams up with leading dermatologist
Tripep has signed a letter of intent with a major Japanese specialty pharma company to bring their wound healing treatment to a big market.
-
New study of toxins and heart disease
Is there a correlation between exposure to hormone interfering environmental toxins and increased risk of developing cardiovascular disease? A new patient study...
-
De ska bli framtidens ledare i global hälsa
Åtta forskare har antagits som Sight fellows hos Swedish institute for global health transformation. De ska utvecklas till ledare i FN:s anda.
-
13 nya ledamöter förstärker IVA
Kungliga Ingenjörsvetenskapsakademien, IVA, har fått nya krafter i form av 13 nya ledamöter.
-
Stärkt skydd för Alzheimerbolag
Alzinova får besked om ytterligare patentskydd på världens största läkemedelsmarknad.
-
Brittisk forskning hamnar efter
Mindre finansiering får Storbritanniens forskning att tappa mark, enligt organisationen Case.
-
DKK 1,3 billion for grand research
Danish Councils for Independent Research, DFF, will grant DKK 1,3 billion during 2009. Now has the application period started.
-
LEO Pharma - International Clinical Trial Manager